OpenFilings

Apellis Pharmaceuticals, Inc.

Form10-K/A

Report Period2023-12-31

Date Filed2024-02-29

Time Filed17:10:01

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-23.2
EX-31.3
EX-31.4
EX-32.3
EX-32.4
Filing on SEC Edgar